Dr. Dave Rabin: Psychedelics and Neuroplasticity, Ketamine Therapy, and Apollo

Description

In this episode of Smarter Not Harder, host Dr. Scott Sherr is joined by guest Dr. Dave Rabin. Dr. Rabin dives into psychedelics, neuroplasticity, ketamine, and his technology Apollo. He also discusses the parasympathetic and sympathetic nervous system and the balance in creating a safe space for patients when they are going through psychedelic assisted psychotherapy or mental health treatment. Dr. Rabin ends the episode by sharing about his nonprofit organization, his most recent W.H.O. adventures, and his talks on psychedelics and ketamine in underdeveloped nations.

Dr. Dave Rabin is a clinical neuroscientist and an M.D. Board certified psychiatrist. He is an M.D. and Ph.D. at the Albany Medical College and specialized in psychiatry with a distinction of research at the Western Psychiatric Institute and clinical at the University of Pittsburgh Medical Center. He is also a health tech entrepreneur. He invented the Apollo and his company, Apollo Neuroscience is creating wearable technology, using touch and simulating touch. Additionally, he co-founded the Board of Medicine and serves as its executive director. Dr. Dave is conducting research on epigenetic regulation of trauma responses and recovery to elucidate the mechanism of psychedelic assisted psychotherapy in the neurobiology of belief.

What we discuss:

00:00:40 - About Dr. Dave Rabin

00:05:18 - About psychedelics and neuroplasticity

00:08:36 - Psychedelics and ketamine

00:12:12 - The mechanisms of ketamine

00:20:21 - Opioid receptors with ketamine being dose dependent

00:27:46 - Balancing the sympathetic and parasympathetic nervous systems

00:34:30 - Dr. Rabin approach to training other doctors and practitioners

00:46:47 - How Dr. Rabin treats his patients in a clinical setting

00:55:30 - The Apollo

01:01:16 - What to prioritize in-session and post-session (ketamine)

01:06:14 - The default mode network